WebMar 12, 2024 · Evolus, Inc. has a 1-year low of $6.51 and a 1-year high of $14.34. The company has a market cap of $455.23 million, a price-to-earnings ratio of -6.11 and a beta of 1.93. Insider Activity WebFeb 7, 2024 · Evolus, Inc. Feb 07, 2024, 07:39 ET. IRVINE, Calif., Feb. 7, 2024 /PRNewswire/ -- Evolus, Inc. ("Evolus"), a medical aesthetics company focused on providing physicians and their patients with ...
EOLS: Evolus Inc - Stock Price, Quote and News - CNBC
WebApr 6, 2024 · EOLS: Get the latest Evolus stock price and detailed information including EOLS news, historical charts and realtime prices. ... Evolus Inc Registered Shs's … WebGet Evolus Inc (EOLS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. filz recycling
Medytox to demand
WebOct 3, 2013 · Evolus Inc., founded in 2012, is headquartered in Santa Barbara, California. The company has a robust and experienced R&D team with international neurotoxin … WebApr 12, 2024 · Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products in the self-pay aesthetic market. Our first … WebOct 4, 2024 · Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2024, the U.S. Food and Drug Administration approved Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi … gruhn\u0027s guitars inventory